ArticlePharmaceutics2024

The Status Quo of Pharmacogenomics of Tyrosine Kinase Inhibitors in Precision Oncology: A Bibliometric Analysis of the Literature.

Abdallah Alzoubi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.